Special Funding II
December 03rd，2020 Press Release
Another Special Funding , Great Bay Bio's Image Recognition-based Cell Expression Prediction Technology and Application was Granted the Second Batch of Guangdong Enterprises' Science and Technology Commissioners Program in 2020
[2020/12/3, Dongguan]On November 19, the project of "Image Recognition Based Cell Expression Prediction Technology and Application" of Dongguan Taili Biotech Co, Ltd., a subsidiary of Great Bay Bio, was awarded the second batch of 2020 Guangdong Enterprise Science and Technology Commissioner Program. This is the second time this month that Great Bay Bio has received this grant.
The image recognition-based cell expression prediction technology and application project is one of the core technologies of Klone4.0, a cell line development platform developed by Great Bay Bio, which can screen hundreds of thousands of cells at a time and obtain cell images. Based on this, Klone4.0 platform utilizes AI technology to rapidly analyze, locate, and select high-yielding cells through AI and precise cell selection technology to obtain high-yielding, high-quality cell lines in four hours, realizing the intelligent application of cell line selection.
About Guangdong Enterprise Science and Technology Commissioner Program
In order to implement the important instructions given by President Xi Jinping on the 20th anniversary of the implementation of the science and technology commissioner system, carry out the "Several Measures on Scientific and Technological Innovation to Support the Resumption of Work and the Smooth Operation of the Economy" (No. 67  of the State Science and Technology Development Zone) and the "Notice of the General Office of the Ministry of Science and Technology on the Special Action of Science and Technology Personnel Service Enterprises" (No. 59  of the State Science and Technology Office),we are actively doing our best to meet the requirements of the following key work of science and technology innovation deployed by the Provincial Science and Technology Innovation Conference, including reforming and improving the province's enterprise science and technology commissioner system, exploring a new model of enterprise science and technology commissioner "oriented to the technology needs of enterprises", attracting global scientific and technological talents to serve Guangdong enterprises' innovation and development, and further developing and strengthening the province's enterprise science and technology commissioner team. To support enterprises to achieve high quality development through innovation and provide strong support for the province to accelerate the implementation of innovation-driven development strategy, the Guangdong Provincial Department of Science and Technology on organizing the 2020 Guangdong Enterprise Science and Technology Commissioner Program was officially launched.
About Great Bay Bio
Headquartered in Hong Kong, Great Bay Bio is a high-tech enterprise dedicated to the development of artificially intelligent biotechnology and biopharmaceutical products. Its subsidiaries, Dongguan Taili Biotech Co., Ltd. and Guangzhou Taili Biomedical Co., Ltd. have invested more than RMB 300 million in R&D equipment and have successfully established an independent and integrated technology platform for drug development and large-scale preparation.
The company has been honored as “Patent Fostering Enterprise”, “Patent Pilot Enterprise”, “National High-tech Enterprise”, “Dongguan City New Type R&D Institution”, and “Top Ten Foreign-funded R&D Center of Guangdong Province”, “Guangdong Provincial Gene Engineering and Pharmaceutical Engineering Research Center”, “Guangdong Provincial Doctoral Workstation”, etc. Since 2006, the company has undertaken a number of government projects and received funding from provincial and national governments for a number of projects, including the "Key Breakthrough Project in Key Areas of Guangdong and Hong Kong" and the "National Major New Drug Discovery Project".
For more details, please visit：www.greatbay-bio.com
Contact for business：email@example.com
Contact for media and investment: firstname.lastname@example.org